Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | RNAC Cartesian Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 2,600 | 0.00 | 508,977 |
2 Jan 25 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 16.93 | 7,800 | 132.05 k | 7,800 |
11 Oct 24 | RNAC Cartesian Therapeutics | Common Stock | Option exercise | Acquire M | Yes | No | 0 | 1,518,373 | 0.00 | 4,555,260 |
11 Oct 24 | RNAC Cartesian Therapeutics | Series A Non-Voting Convertible Preferred Stock Common Stock | Option exercise | Dispose M | Yes | No | 0 | 45,551.19 | 0.00 | 56,402.254 |
8 Apr 24 | RNAC Cartesian Therapeutics | Common Stock | Option exercise | Acquire M | Yes | No | 0 | 2,926,764 | 0.00 | 3,036,887 |
8 Apr 24 | RNAC Cartesian Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 491,853 | 0.00 | 506,377 |
8 Apr 24 | RNAC Cartesian Therapeutics | Series A Non-Voting Convertible Preferred Stock Common Stock | Option exercise | Dispose M | Yes | No | 0 | 87,802.95 | 0.00 | 101,953.444 |
8 Apr 24 | RNAC Cartesian Therapeutics | Series A Non-Voting Convertible Preferred Stock Common Stock | Option exercise | Dispose M | No | No | 0 | 14,755.609 | 0.00 | 0 |
2 Jan 24 | RNAC Cartesian Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 178,000 | 0.00 | 435,739 |
2 Jan 24 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6552 | 228,000 | 149.39 k | 228,000 |